You are here
Award Data
The Award database is continually updated throughout the year. As a result, data for FY24 is not expected to be complete until March, 2025.
Download all SBIR.gov award data either with award abstracts (290MB)
or without award abstracts (65MB).
A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.
The SBIR.gov award data files now contain the required fields to calculate award timeliness for individual awards or for an agency or branch. Additional information on calculating award timeliness is available on the Data Resource Page.
-
Radio Frequency Catalytic Decontamination
SBC: Zeteo Tech, Inc. Topic: 15NCER07The novel RFCAT technology will allow for safe and rapid decontamination of biological agents on railroad and subway cars. The technology creates biocidal conditions on external and internal surfaces of the rail and subway cars. The technology has been demonstrated on building materials and will be modified for the surfaces found in rail and subway cars. Additionally the system will kill odor and ...
SBIR Phase I 2016 Environmental Protection Agency -
ARCHER- An Extremely Fast Medical Radiation Dose Computing Software
SBC: VIRTUAL PHANTOMS INC Topic: NIBIBDESCRIPTION provided by applicant The goal of this project is to develop a commercial software package for rapid Monte Carlo based dose computation in imaging and radiation therapy The product takes advantage of a desktop parallel computer equipped with emerging hardware originally developed gaming and high performance computing The project is motivated by the fact that the market is ripe for ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Multi-Modality Image Data Fusion and Machine Learning Approaches for Personalized Diagnostics and Prognostics of MCI due to AD
SBC: MS Technologies Corporation Topic: NIAAlzheimer s Disease AD is the most common form of dementia and the sixth leading cause of death in the US More than million people in the US currently have AD and the direct health care cost is over $ billion per year Detection of early phase of AD namely Mild Cognitive Impairment MCI can delay prevent and treat this serious disease The project will develop a clinically feasible sy ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
A NEW HOLOGRAPHIC 3D CAMERA FOR FUNDUS IMAGING
SBC: CELLOPTIC Topic: NA NEW HOLOGRAPHIC D CAMERA FOR FUNDUS IMAGING Abstract In the United States retinal disease is the most common cause of visual impairment with age related macular degeneration AMD and diabetic retinopathy DR being the most common retinal diseases For each of the above conditions high resolution and three dimensional D imaging of the retina retinal vasculature choroid and or retinal ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Building a Low Cost High Density Data Gathering Platform For Studying High-functioning Elders
SBC: Human Project Inc. Topic: NIABy the time an individual is diagnosed with Alzheimer s Disease AD or dementia they have often already experienced both gradual and dramatic changes to their health cognitive function employment and financial status among other life events A number of key interview based studies like The National Health and Aging Trends Study NHATS and The Health and Retirement Study HRS have provided u ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Sylvatica I-Corps Commercialization March2017- Isochoric Pressure Based Preservation of Ovarian Tissue
SBC: SYLVATICA BIOTECH INC Topic: NICHDPROJECT SUMMARY ABSTRACTThis program aims to develop a novel storage method for human ovarian tissue and whole ovarieswhich can also be applied to testicular tissue and gonadal preservation as well as a variety of cellstissuesand whole organsThis multi pronged approach builds on recent advances in machine perfusionnature inspired cytoprotection strategiesand non toxic cryoprotectant solutionscombi ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Human-derived hemoglobin based oxygen carrier for utilization in organ and tissue preservation
SBC: Virtech Bio, Inc. Topic: 400This project aims to develop a human derived Hemoglobin Based Oxygen Carrier HBOC solution Phase I to be utilized in numerous ex vivo applications Phase II where an oxygen delivery solution is required machine perfusion MP systems for organ and tissue preservation MP systems for the discovery of biomarkers and perfusate in human microchips for drug discovery This is the first ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Joint angle transform based methodology for controlling upper limb prostheses
SBC: INFINITE BIOMEDICAL TECHNOLOGIES, LLC Topic: NICHDJoint angle transform based methodology for controlling upper limb prostheses ABSTRACT Care of upper limb amputees is a great example of personalized medicine Prosthetists and occupational therapists work with patients to identify their needs and then to create a highly individualized solution using a variety of components and technologies The key to improving care in this underserved patient p ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Proteasome inhibitor re-sensitizing molecules for treatment of refractory multiple myeloma
SBC: LEUKOGENE THERAPEUTICS INC Topic: 102Project Summary Abstract Multiple Myeloma MM is the second most common form of blood cancer and remains an incurable and deadly disease Proteasome inhibitor PI therapy is a cornerstone in the treatment of MM but resistance to this class of agent is an emerging challenge in the clinic New therapeutic approaches that specifically target resistance are needed to maximize responses and ultimate ...
STTR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health -
Pharmacological Validation of GIV/Girdin, a Guanine Nucleotide Exchange Factor, for Liver Fibrosis
SBC: Bellbrook Labs, LLC Topic: NProject Summary The broad goal of this project is the pharmacological validation of GIV a nonreceptor guanine nucleotide exchange factor GEF for liver fibrosis GIV sits at the hub of profibrogenic signaling in liver fibrosis and is required for the key physiological events that lead to this condition the migration proliferation and extracellular matrix deposition of hepatic stellate cells ...
SBIR Phase I 2016 Department of Health and Human ServicesNational Institutes of Health